Braemar Hotels & Resorts Inc
Change company Symbol lookup
Select an option...
BHR Braemar Hotels & Resorts Inc
NBSTU Newbury Street Acquisition Corp
SKX Skechers USA Inc
IGICW International General Insurance Holdings Equity Warrants 17th March 2025 *W EXP 03/17/2025
NHIC Newhold Investment II Corp
MMI Marcus & Millichap Inc
PEN Penumbra Inc
IGIC International General Insurance Holdings Ltd
Z Zillow Group Inc
SLP Simulations Plus Inc

Real Estate : Equity Real Estate Investment Trusts (REITs) | Small Cap Value
Company profile

Braemar Hotels & Resorts Inc. is a real estate investment trust (REIT) that invests primarily in high revenue per available room (RevPAR), luxury hotels and resorts. The Company conducts its business and owns all of its assets through its operating partnership, Braemar Hospitality Limited Partnership (Braemar OP). It operates in the direct hotel investment segment of the hotel lodging industry. It owns interests in approximately 14 hotel properties in six states, the District of Columbia and St. Thomas, the United States, Virgin Islands with approximately 3,875 total rooms. The Company owns 12 of its hotel properties directly, and the remaining two hotel properties through an investment in a majority-owned consolidated entity. The Company's hotel properties include Marriott Seattle Waterfront, Sofitel Chicago Magnificent Mile, The Ritz-Carlton St. Thomas, The Ritz-Carlton Sarasota, Bardessono Hotel and Spa, The Ritz-Carlton Lake Tahoe, Pier House Resort & Spa, and Dorado Beach.

Closing Price
Day's Change
-0.17 (-3.62%)
B/A Size
Day's High
Day's Low

10-day average volume:

Bio-Rad to Report First-Quarter Financial Results, Thursday, April 28, 2022

8:00 am ET April 18, 2022 (BusinessWire) Print

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global leader of life science research and clinical diagnostic products, will report financial results for the first quarter 2022 on Thursday, April 28, 2022, following the close of the market. The company will discuss these results in a conference call scheduled for 3 PM Pacific Time (6 PM Eastern Time) that day.

To listen, call 844-200-6205 within the U.S. or 929-526-1599 outside the U.S., access code: 493268. You may also listen to the conference call live via webcast that is available on the "Investor Relations" section of our website under "Events & Presentations" at A replay of the webcast will be available for up to a year.

About Bio-Rad

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 7,900 employees worldwide. Bio-Rad had revenues of $2.9 billion in 2021. For more information, please visit

View source version on

SOURCE: Bio-Rad Laboratories, Inc.

Bio-Rad Laboratories, Inc.
Edward Chung, Vice President, Investor Relations
comtex tracking


Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.